Gontivimab

DB16179Investigational

Gontivimab is under investigation in clinical trial NCT03468829 (Efficacy and Safety of ALX-0171 in Adult Hematopoietic Stem Cell Transplant (HSCT) Recipients Who Present With Respiratory Syncytial Virus (RSV) Infection).

Mechanism: Pharmacologically active on Fusion glycoprotein F0
Curator reviewed
Also known as: Anti-rsv protein f nanobody alx-0171
Code names: ALX-0171

Resolves to

Compound

UNIIDY8W536BUYCAS1257358-38-5

Targets

P12568F

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Gontivimab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account